Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · IEX Real-Time Price · USD
2.420
-0.030 (-1.22%)
At close: Jul 2, 2024, 4:00 PM
2.500
+0.080 (3.31%)
After-hours: Jul 2, 2024, 7:42 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $220.31 million as of July 2, 2024. Its market cap has increased by 115.36% in one year.
Market Cap
220.31M
Enterprise Value
240.25M
1-Year Change
115.36%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has decreased from $385.20M to $220.31M, a decrease of -42.81%. That is a compound annual growth rate of -8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 223.00M | 65.31% |
| Dec 29, 2023 | 134.90M | 176.43% |
| Dec 30, 2022 | 48.80M | -68.76% |
| Dec 31, 2021 | 156.20M | -13.17% |
| Dec 31, 2020 | 179.90M | 23.39% |
| Dec 31, 2019 | 145.80M | -7.19% |
| Dec 31, 2018 | 157.10M | -59.22% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 226.71M |
| CorMedix | 226.43M |
| Greenwich LifeSciences | 226.43M |
| Cibus | 226.16M |
| Omeros | 223.09M |
| Delcath Systems | 219.79M |
| Monte Rosa Therapeutics | 219.53M |
| ESSA Pharma | 218.71M |